SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study

The SEARCH Collaborative Group·2008·New England Journal of Medicine

DOI 10.1056/nejmoa0801936

Cited by (1,002)

Items 801–900 of 1,002

ADME Pharmacogenetics: Future Outlook for Russia
Karin Badavievich Mirzaev, Denis S. Fedorinov, Dmitriy V. Ivashchenko, Dmitry Alekseevich Sychev · 2019 · Pharmacogenomics
Recent advances in preclinical in vitro approaches towards quantitative prediction of hepatic clearance and drug-drug interactions involving organic anion transporting polypeptide (OATP) 1B transporters
Yoshitane Nozaki, Saki Izumi · 2019 · Drug Metabolism and Pharmacokinetics
Individualized Medication Management in Ontario Long-Term Care Clinical Impact on Management of Depression, Pain, and Dementia
Ruslan Dorfman, Zana London, Mark Metias, Boyko Kabakchiev, Gouri Mukerjee, Andrea L. Moser · 2020 · Journal of the American Medical Directors Association
Familial hypercholesterolemia in Southeast and East Asia
Candace L. Jackson, Magdi Zordok, Iftikhar J. Kullo · 2021 · American Journal of Preventive Cardiology
Is personalized medicine a dream or a reality?
Bridget L. Morse, Richard B. Kim · 2014 · Critical Reviews in Clinical Laboratory Sciences
A Small-Molecule Screening Strategy To Identify Suppressors of Statin Myopathy
Bridget K. Wagner, Tamara J. Gilbert, Jun‐ichi Hanai, Shintaro Imamura, Nicole E. Bodycombe, Robin S. Bon, Herbert Waldmann, Paul A. Clemons, Vikas P. Sukhatme, Vamsi Krishna Mootha · 2011 · ACS Chemical Biology
CoQ10 and L-carnitine for statin myalgia?
James J. DiNicolantonio · 2012 · Expert Review of Cardiovascular Therapy
Applied Pharmacogenomics in Cardiovascular Medicine
Peter Weeke, Dan M. Roden · 2013 · Annual Review of Medicine
New Drug Approvals: Pitavastatin: A New HMG-CoA Reductase Inhibitor
Terri M. Wensel, Bruce A. Waldrop, Brian Wensel · 2010 · Annals of Pharmacotherapy
Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy
Frédérique Rodieux, Verena Gotta, Marc Pfister, Johannes N. van den Anker · 2016 · The Journal of Clinical Pharmacology
Fatal Statin-Induced Rhabdomyolysis by Possible Interaction with Palbociclib
Kellie Lynn Nelson, David Dean Stenehjem, Meghan Driscoll, Glynn Weldon Gilcrease · 2017 · Frontiers in Oncology
Genetic determinants of response to statins
Bas J.M. Peters, Olaf H. Klungel, Anthonius de Boer, Anke H. Maitland‐van der Zee · 2009 · Expert Review of Cardiovascular Therapy
The Impact of Improved Microarray Coverage and Larger Sample Sizes on Future Genome‐Wide Association Studies
Karla J. Lindquist, Eric Jorgenson, Thomas J. Hoffmann, John S. Witte · 2013 · Genetic Epidemiology
Database of optimized proteomic quantitative methods for human drug disposition-related proteins for applications in physiologically based pharmacokinetic modeling
Vrana, M, Whittington, D, Nautiyal, V, Prasad, B · 2017 · CPT: Pharmacometrics & Systems Pharmacology
Statin Myopathy: A Lipid Clinic Experience on the Tolerability of Statin Rechallenge
Fung, En C., Crook, Martin A. · 2012 · Cardiovascular Therapeutics
A conceptual framework for pharmacodynamic genome-wide association studies in pharmacogenomics
Rongling Wu, Chunfa Tong, Zhong Wang, David T. Mauger, Kelan G. Tantisira, Stanley James Szefler, Vernon M. Chinchilli, Elliot Israel · 2011 · Drug Discovery Today
Development of a High-Affinity Inhibitor of the Prostaglandin Transporter
Yuling Chi, Jaeki Min, Jean-François Jasmin, Michael P. Lisanti, Young‐Tae Chang, Victor L. Schuster · 2011 · Journal of Pharmacology and Experimental Therapeutics
Cardiovascular Pharmacogenomics: Current Status and Future Directions—Report of a National Heart, Lung, and Blood Institute Working Group
Kiran Musunuru, Dan M. Roden, Robin Boineau, Michael R. Bristow, Timothy A. McCaffrey, Christopher Newton‐Cheh, Dina N. Paltoo, Yves Rosenberg, Jay G. Wohlgemuth, Issam Zineh et al. · 2012 · Journal of the American Heart Association
SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway
Tanda Murray Dudenkov, James N. Ingle, Aman U. Buzdar, Mark E. Robson, Michiaki Kubo, Irada Ibrahim-zada, Anthony J. Batzler, Gregory D. Jenkins, Tracy L. Pietrzak, Erin E. Carlson et al. · 2017 · Breast Cancer Research and Treatment
Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?
Enrica Rossini, Federico Biscetti, Maria Margherita Rando, Elisabetta Nardella, Andrea Leonardo Cecchini, Maria Anna Nicolazzi, Marcello Covino, Antonio Gasbarrini, Massimo Massetti, Andrea Flex · 2022 · International Journal of Molecular Sciences
Genetic heterogeneity in cardiovascular disease across ancestries: Insights for mechanisms and therapeutic intervention
Opeyemi S. Soremekun, Marie‐Joe Dib, Skanda Rajasundaram, Segun Fatumo, Dipender Gill · 2023 · Cambridge Prisms Precision Medicine
Preincubation Time-Dependent, Long-Lasting Inhibition of Drug Transporters and Impact on the Prediction of Drug−Drug Interactions
Yoshitane Nozaki, Saki Izumi · 2023 · Drug Metabolism and Disposition
Pharmacogenomics of Hypertension and Heart Disease
Meghan J. Arwood, Larisa H. Cavallari, Julio D. Duarte · 2015 · Current Hypertension Reports
The effects of a single nucleotide polymorphism in SLCO1B1 on the pharmacodynamics of pravastatin
Nicholas G. Martin, KaWah Li, Heather M. Murray, W. Putt, Chris J. Packard, Steve Eric Humphries · 2011 · British Journal of Clinical Pharmacology
Impact of New Genomic Technologies on Understanding Adverse Drug Reactions
Simran D. S. Maggo, Ruth L Savage, Martin Alexander Kennedy · 2015 · Clinical Pharmacokinetics
Nonalcoholic steatohepatitis in precision medicine: Unraveling the factors that contribute to individual variability
John Clarke, Nathan J. Cherrington · 2015 · Pharmacology & Therapeutics
Identification of genetic polymorphisms of human OAT1 and OAT2 genes and their relationship to hOAT2 expression in human liver
Ho Jung Shin, Choong-Hee Lee, Sang Seop Lee, Im‐Sook Song, Jae‐Gook Shin · 2009 · Clinica Chimica Acta
Statins in clinical medicine
Jonas Rutishauser · 2011 · Swiss Medical Weekly
HMGCR rs17671591 SNP Determines Lower Plasma LDL ‐C after Atorvastatin Therapy in Chilean Individuals
Alejandro Cuevas, César Fernández, Luis Ferrada, Tomás Zambrano, Alexy Rosales, Nicolás Saavedra, Luis Antonio Salazar · 2015 · Basic & Clinical Pharmacology & Toxicology
Modelling of atorvastatin pharmacokinetics and the identification of the effect of a BCRP polymorphism in the Japanese population
Nikolaos Tsamandouras, Yingying Guo, Thierry Wendling, Stephen David Hall, Aleksandra Galetin, Leon J Aarons · 2016 · Pharmacogenetics and Genomics
Cholesterol-Lowering Drugs
E.L. Albuquerque, Umberto Laino Fulco, E. W. S. Caetano, V. N. Freire · 2020 · Cambridge University Press eBooks
Influence of Single Nucleotide Polymorphisms on Rifampin Pharmacokinetics in Tuberculosis Patients
Levin Thomas, Sonal Sekhar Miraj, Surulivelrajan Mallayasamy, Muralidhar D Varma, Chidananda Sanju, Mahadev Rao · 2020 · Antibiotics
Phenotype prediction and characterization of 25 pharmacogenes in Thais from whole genome sequencing for clinical implementation
John Mauleekoonphairoj, Monpat Chamnanphon, Apichai Khongphatthanayothin, Boosamas Sutjaporn, Pharawee Wandee, Yong Poovorawan, Koonlawee Nademanee, Monnat Pongpanich, Pajaree Chariyavilaskul · 2020 · Scientific Reports
Drug Transporter Function—Implications in CKD
Michael H. Schwenk, Amy Barton Pai · 2016 · Advances in Chronic Kidney Disease
Jumping on the Train of Personalized Medicine: A Primer for Non- Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area
Aihua Li, David Meyre · 2014 · Current Psychiatry Reviews
Is Statin-Induced Myositis Part of the Polymyositis Disease Spectrum?
Jemima Albayda, Andrew Lee Mammen · 2014 · Current Rheumatology Reports
Skeletal muscle ultrastructure and function in statin-tolerant individuals
Jason L. Rengo, Damien M. Callahan, Patrick D. Savage, Philip A. Ades, Michael J. Toth · 2015 · Muscle & Nerve
Pharmacogenetics of HMG-CoA Reductase Inhibitors: Optimizing the Prevention of Coronary Heart Disease
Miao Hu, Valiant W.L. Mak, T. Chu, Mary Miu Yee Waye, Brian Tomlinson · 2009 · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine
Bile Secretion and the Enterohepatic Circulation
Paul A. Dawson · 2010 · Elsevier eBooks
A genetic risk score is significantly associated with statin therapy response in the elderly population
Diana Maria Ciuculete, Marcus Bandstein, Christian Benedict, Gérard Waeber, Péter Vollenweider, Lars Lind, Helgi B. Schiöth, Jessica Mwinyi · 2016 · Clinical Genetics
Elucidation of OATP1B1 and 1B3 transporter function using transgenic rodent models and commonly known single nucleotide polymorphisms
Supratim Choudhuri, Curtis D. Klaassen · 2020 · Toxicology and Applied Pharmacology
Multi-factorial pharmacokinetic interactions: unraveling complexities in precision drug therapy
Baron J. Bechtold, John Clarke · 2020 · Expert Opinion on Drug Metabolism & Toxicology
Pharmacogenomics in Cardiovascular Diseases
Caitrin W. McDonough · 2021 · Current Protocols
Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes
Sarudzai Muyambo, Arinao Ndadza, Nyarai Desiree Soko, Bianca Kruger, Gerard Kadzirange, Emile Rugamika Chimusa, Collen Mutowembwa Masimirembwa, Mpiko Ntsekhe, Charles F. B. Nhachi, Collet Dandara · 2021 · OMICS A Journal of Integrative Biology
Statin-related Muscle Toxicity: An Evidence-based Review
Mohammad Sadiq Jeeyavudeen, Joseph M Pappachan, Ganesan Arunagirinathan · 2022 · touchREVIEWS in Endocrinology
Statin-associated muscle symptoms EAS Consensus Panel paper focuses on this neglected patient group
Jane K. Stock · 2015 · Atherosclerosis
Effects ofGinkgo bilobaextracts on pharmacokinetics and efficacy of atorvastatin based on plasma indices
Cheng-Xian Guo, Qi Pei, Ji‐Ye Yin, Xiangdong Peng, Bo-Ting Zhou, Ying-Chun Zhao, Lan-Xiang Wu, Xiang-Guang Meng, Guo Wang, Qing Li et al. · 2012 · Xenobiotica
Medical DNA sequencing
Ali J. Marian · 2011 · Current Opinion in Cardiology
Genetics and Personalized Medicine—a Role in Statin Therapy?
Jaideep Patel, Thura Abd, Roger Scott Blumenthal, Khurram Nasir, H. Robert Superko · 2013 · Current Atherosclerosis Reports
Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 Proteins
Dustin R. Walsh, Thomas D. Nolin, Peter A. Friedman · 2015 · Pharmacological Reviews
Oatp1a1 Requires PDZK1 to Traffic to the Plasma Membrane by Selective Recruitment of Microtubule-Based Motor Proteins
Wen-Jun Wang, John W. Murray, Allan W. Wolkoff · 2013 · Drug Metabolism and Disposition
Fundamentals of Complex Trait Genetics and Association Studies
Jahad Alghamdi, Sandosh Padmanabhan · 2014 · Elsevier eBooks
Genetic Variations and Frequencies of the Two Functional Single Nucleotide Polymorphisms of SLCO1B1 in the Thai Population
Chalitpon Na Nakorn, Jariya Waisayarat, Charungthai Dejthevaporn, Pornpen Srisawasdi, Sansanee Wongwaisayawan, Chonlaphat Sukasem · 2020 · Frontiers in Pharmacology
Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug–drug interaction
Srečko Marušić, Ante Lisičić, Ivica Horvatić, Vesna Bačić-Vrca, Nada Božina · 2012 · International Journal of Clinical Pharmacy
UGT1A1*28 is Associated with Decreased Systemic Exposure of Atorvastatin Lactone
Camilla Stormo, Martin Prøven Bogsrud, Monica Hermann, Anders Åsberg, Armin P. Piehler, Kjetil Retterstøl, Marianne Kristiansen Kringen · 2013 · Molecular Diagnosis & Therapy
Organic Anion Uptake by Hepatocytes
Allan W. Wolkoff · 2014 · Comprehensive physiology
Risk and preventive factors of low‐dose aspirin‐induced gastroduodenal injuries: A comprehensive review
Akiko Shiotani, Noriaki Manabe, Tomoari Kamada, Yoshinori Fujimura, Takashi Sakakibara, Ken Haruma · 2012 · Journal of Gastroenterology and Hepatology
Pharmacogenomic insights into treatment and management of statin-induced myopathy
Bas J.M. Peters, Olaf H. Klungel, Frank L.J. Visseren, Anthonius de Boer, Anke H. Maitland‐van der Zee · 2009 · Genome Medicine
Impaired Hepatic Uptake by Organic Anion-Transporting Polypeptides Is Associated with Hyperbilirubinemia and Hypercholanemia in Atp11c Mutant Mice
Yusuke Matsuzaka, Hisamitsu Hayashi, Hiroyuki Kusuhara · 2015 · Molecular Pharmacology
Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia
Miao Hu, Brian Tomlinson · 2012 · Atherosclerosis
Molecular insights from dysregulation of the thiazide‐sensitive WNK / SPAK / NCC pathway in the kidney: Gordon syndrome and thiazide‐induced hyponatraemia
Mark Glover, Kevin M. O’Shaughnessy · 2013 · Clinical and Experimental Pharmacology and Physiology
Genetic determinants of response to cardiovascular drugs
Quinn Stanton Wells, Jessica T. Delaney, Dan M. Roden · 2012 · Current Opinion in Cardiology
Use of an Electronic Medical Record to Characterize Cases of Intermediate Statin‐Induced Muscle Toxicity
Ravi K. Mareedu, Falgun Modhia, Elenita I. Kanin, James G. Linneman, Terrie Kitchner, Catherine Anne McCarty, Ronald M. Krauss, Russell A. Wilke · 2009 · Preventive Cardiology
Pharmacogenetic screening for drug therapy: From single gene markers to decision making in the next generation sequencing era
Mladen Vassilev Tzvetkov, Nicolas von Ahsen · 2012 · Pathology
Tailored Therapy of ACE Inhibitors in Stable Coronary Artery Disease: Pharmacogenetic Profiling of Treatment Benefit
Jasper Jan Brugts, Eric H. Boersma, Maarten L. Simoons · 2010 · Pharmacogenomics
Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia
Antonio M. Gotto, Jennifer Moon · 2010 · Expert Review of Cardiovascular Therapy
Statin-related myotoxicity
Vera Fernandes, Maria Joana Santos, Antonio Pérez · 2016 · Endocrinología y Nutrición
Cytochrome P450 drug interactions with statin therapy
Ivanna Xin Wei Goh, Choon How How, S Tavintharan · 2013 · Singapore Medical Journal
SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study
Toralf Reimer, Sarah Kempert, Bernd Gerber, Hans‐Jürgen Thiesen, Steffi Hartmann, Dirk Koczan · 2016 · BMC Cancer
Statin intolerance – a question of definition
Engi Abd Elhady Algharably, Iris Filler, Stephanie Rosenfeld, Katja Grabowski, Reinhold Hugo Kreutz · 2016 · Expert Opinion on Drug Safety
Statins for primary prevention and rhabdomyolysis: A nationwide cohort study in France
Jöel Coste, Cécile Billionnet, Annie Rudnichi, J. Pouchot, Rosemary Dray‐Spira, Philippe Giral, Mahmoud Zureik · 2018 · European Journal of Preventive Cardiology
Simvastatin Treatment Protects Myocardium in Noncoronary Artery Cardiac Surgery by Inhibiting Apoptosis Through miR-15a-5p Targeting
Li Zhou, Xiang Liu, Zhen-Qing Wang, Yan Li, Mao‐Mao Shi, Zhe Xu, Zhi‐Jun Ou, Hua-Ming Li, Tian-Pu Cheng, Yu‐Peng Jian et al. · 2018 · Journal of Cardiovascular Pharmacology
Lipid Screening, Action, and Follow-up in Children and Adolescents
Albert Wiegman · 2018 · Current Cardiology Reports
Approaching sites of action of drugs in clinical pharmacology: New analytical options and their challenges
Rémi Longuespée, Dirk Theile, Margaux Fresnais, Jürgen Burhenne, Johanna Weiß, Walter E. Haefeli · 2020 · British Journal of Clinical Pharmacology
Pharmacogenetic information in Swiss drug labels – a systematic analysis
Chiara Jeiziner, Katja Suter, Ursina Wernli, Julia M. Barbarino, Li Gong, Michelle Whirl‐Carrillo, Teri E. Klein, Thomas D. Szucs, Kurt E. Hersberger, Henriette E. Meyer zu Schwabedissen · 2020 · The Pharmacogenomics Journal
Genotype-Based Risk and Pharmacogenetic Sampling in Clinical Trials
Nicholas J. Schork, Eric J. Topol · 2010 · Journal of Biopharmaceutical Statistics
Emerging Toxic Neuropathies and Myopathies
Hani A. Kushlaf · 2011 · Neurologic Clinics
HapMap and Mapping Genes for Cardiovascular Disease
Kiran Musunuru, Sekar Kathiresan · 2008 · Circulation Cardiovascular Genetics
Pharmacogenetics and Stroke
James Frederick Meschia · 2009 · Stroke
Pharmacogenomic and Personalized Approaches to Tackle Nonalcoholic Fatty Liver Disease
Gregor Lorbek, Žiga Urlep, Damjana Rozman · 2016 · Pharmacogenomics
The Effect of Genetic Polymorphisms in SLCO2B1 on the Lipid‐Lowering Efficacy of Rosuvastatin in Healthy Adults with Elevated Low‐Density Lipoprotein
Tae‐Eun Kim, Dongseong Shin, Namyi Gu, Byung Hwa Jung, Jayoun Kim, Young Min Cho, Kyung‐Sang Yu, Joo‐Youn Cho · 2017 · Basic & Clinical Pharmacology & Toxicology
SLCO1B1 genetic variation and hormone therapy in menopausal women
Ann M. Moyer, Mariza de Andrade, Stephanie S. Faubion, Ekta Kapoor, Tanda Murray Dudenkov, Richard M. Weinshilboum, Virginia M. Miller · 2018 · Menopause The Journal of The North American Menopause Society
Cardiovascular Risk and Its Presentation in Chronic Kidney Disease
Stefan J. Schunk, Paul Zimmermann · 2025 · Journal of Clinical Medicine
Immune-mediated statin myopathy
Priyadarshini Loganathan, Chester V. Oddis, Rohit Aggarwal · 2015 · Expert Review of Clinical Immunology
Comments on the 2011 ESC/EAS guidelines for the management of dyslipidemias. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology
Manuel P. Anguita, Eduardo Alegría, Vivencio Barrios, José Antonio Casasnovas, Carlos Escobar, Monserrat León, Emilio Luengo, José L. Llisterri, Ángel Alonso, Angel R. Cequier et al. · 2011 · Revista Española de Cardiología (English Edition)
SLCO1B1 variants as predictors of methotrexate-related toxicity in children with juvenile idiopathic arthritis
Justyna Roszkiewicz, Dominika A. Michalek, Aleksandra Ryk, Zbigniew Swacha, Bartosz M. Szmyd, Elżbieta Barbara Smolewska · 2020 · Scandinavian Journal of Rheumatology
Flavonoid-statin interactions causing myopathy and the possible significance of OATP transport, CYP450 metabolism and mevalonate synthesis
Joshua Zechner, Susan M. Britza, Rachael Farrington, Roger W. Byard, Ian Musgrave · 2021 · Life Sciences
An Integratedin VitroModel for Simultaneous Assessment of Drug Uptake, Metabolism, and Efflux
Etienne P.A. Neve, Per Artursson, Magnus Ingelman‐Sundberg, Maria Karlgren · 2013 · Molecular Pharmaceutics
MRI in Lipid-Lowering Agent–Associated Myopathy: A Retrospective Review of 21 Cases
Soeren Andrew Peters, Rudolf Andre Kley, Martin Tegenthoff, Matthias Vorgerd, Volkmar Nicolas, Christoph M. Heyer · 2010 · American Journal of Roentgenology
Intronic variants in SLCO1B1 related to statin-induced myopathy are associated with the low-density lipoprotein cholesterol response to statins in Chinese patients with hyperlipidaemia
Miao Hu, Valiant W.L. Mak, Brian Tomlinson · 2012 · Pharmacogenetics and Genomics
Simvastatin-induced compartmentalisation of doxorubicin sharpens up nuclear topoisomerase II inhibition in human rhabdomyosarcoma cells
Martin Werner, Bihter Atil, Evelyn Berger–Sieczkowski, Peter Chiba, Martin HOHENEGGER · 2013 · Naunyn-Schmiedeberg s Archives of Pharmacology
The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemia
Paulo C.J.L. Santos, Aline Morgan Alvarenga, Cinthia E. Jannes, José Eduardo Krieger, Raul Dias Santos, Alexandre C. Pereira · 2014 · Pharmacogenetics and Genomics
Prospects of personalized medicine in cardiovascular diseases
Claude J. M. Lenfant · 2012 · Metabolism
Atorvastatin Metabolite Measurements as a Diagnostic Tool for Statin-Induced Myopathy
Ine Blankenberg Skottheim, Martin Prøven Bogsrud, Monica Hermann, Kjetil Retterstøl, Anders Åsberg · 2011 · Molecular Diagnosis & Therapy
Classical Twin Design in Modern Pharmacogenomics Studies
Nilüfer Rahmioğlu, Kourosh R. Ahmadi · 2010 · Pharmacogenomics
Associations Between the Genotypes and Phenotype of CYP3A and the Lipid Response to Simvastatin in Chinese Patients with Hypercholesterolemia
Miao Hu, Valiant W.L. Mak, Yajie Xiao, Brian Tomlinson · 2012 · Pharmacogenomics
The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin
Miao Hu, Sandra S.H. Lui, Lai‐Shan Tam, Edmund K. Li, Brian Tomlinson · 2012 · Journal of Lipid Research
Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia
Htet Khine, Wei Cheng Yuet, BEVERLEY A. ADAMS-HUET, Zahid Ahmad · 2016 · American Heart Journal
Renal Tubular Toxicity Associated With Rosuvastatin Therapy
Frank L. Ward, Rohan John, Joanne M. Bargman, Rory McQuillan · 2016 · American Journal of Kidney Diseases
No Effect of SLCO1B1 and CYP3A4/5 Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Male Subjects
Mu-Peng Li, Yaodong Hu, Huilan Li, Zhipeng Wen, Xiaolei Hu, Daoyu Zhang, Yanjiao Zhang, Jian Ru Xiao, Jie Tang, Xiaoping Chen · 2016 · Biological and Pharmaceutical Bulletin